Online skin cancer risk assessment tool can predict non-melanoma skin cancer
A new online tool allows people to assess their risks of developing skin cancer in the next three years. Aimed at people over 40, the tool determines the risk level in only a few questions. (Source: the Mail online | Health)
Source: the Mail online | Health - March 24, 2016 Category: Consumer Health News Source Type: news
Sensus Healthcare sets terms on $20m IPO
Sensus Healthcare yesterday set the terms on an initial public offering that would raise $20 million at the mid-point.
Boca Raton, Fla.-based Sensus makes the SRT-100 and SRT-100 Vision photon X-ray low-energy superficial radiotherapy systems for treating non-melanoma skin cancers, including basal cell and squamous cell carcinoma.
Sensus said it plans to float more than 1.8 million shares at $10 to $12 apiece, working out to a low-end raise of $18.2 million and a high end of $21.8 million.
Sensus said it’s won 510(k) clearance from the FDA, CE Mark approval in the European Union and nods from the China Food & D...
Source: Mass Device - March 10, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Radiosurgery Sensus Healthcare LLC Source Type: news
New NICE guidelines on sun exposure warn 'tanning is unsafe'
"No safe way to suntan, new NICE guidance warns," BBC News reports. The guidelines, produced by the National Institute for Health and Care Excellence (NICE), also stresses the benefits of moderate sun exposure.
This will help prevent vitamin D deficiency; which is more common in the UK than many people realise. It is estimated that around one in five adults and older children (aged between 11 and 18) have low vitamin D status. The figure is around one in seven for younger children.
What are the risks of overexposure?
Sunlight contains ultraviolet A (UVA) and ultraviolet B (UVB) radiation, both of which can b...
Source: NHS News Feed - February 10, 2016 Category: Consumer Health News Tags: Lifestyle/exercise Cancer QA articles Source Type: news
Average person with atopic dermatitis has no increased risk of actinic keratosis or nonmelanoma skin cancer
People with atopic dermatitis do not appear to be at greater risk for actinic keratosis or basal cell and squamous cell cancer, according to a recent population-based, cross-sectional study.
“This is the first study to examine the association between atopic dermatitis and actinic keratosis [AK].... (Source: Skin and Allergy News)
Source: Skin and Allergy News - February 8, 2016 Category: Dermatology Source Type: news
Vitamin Prevents Skin Cancer: Only in Australia?Vitamin Prevents Skin Cancer: Only in Australia?
A phase 3 trial indicates that daily vitamin B3 prevents nonmelanoma skin cancer in high-risk patients. But experts wonder if it applies to other lands with different people. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 23, 2015 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Medical News Today: Carcinoma: Basal Cell and Squamous Cell Carcinoma
Learn about the signs and symptoms of two forms of non-melanoma skin cancer and how they are diagnosed and treated. Also find out the best ways to prevent carcinoma. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 22, 2015 Category: Consumer Health News Tags: Melanoma / Skin Cancer Source Type: news
B Vitamin May Help Ward Off Some Skin Cancers
Study found high-risk patients who took nicotinamide daily developed fewer non-melanoma lesions (Source: WebMD Health)
Source: WebMD Health - October 22, 2015 Category: Consumer Health News Source Type: news
B Vitamin May Help Ward Off Some Skin Cancers
Study found high-risk patients who took nicotinamide daily developed fewer non-melanoma lesions (Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - October 22, 2015 Category: Cancer & Oncology Source Type: news
Vitamin B3 Tied to Lower Risk for Nonmelanoma Skin Cancer (FREE)
By Kelly Young
Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM
Nicotinamide, a form of vitamin B3, is associated with reduced risk for developing nonmelanoma skin cancer among … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 22, 2015 Category: Primary Care Source Type: news
B Vitamin May Help Ward Off Some Skin Cancers
Study found high-risk patients who took nicotinamide daily developed fewer non-melanoma lesions (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 21, 2015 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Dermatology, Oncology, Nutrition, News, Source Type: news
B Vitamin May Help Ward Off Some Skin Cancers
Study found high-risk patients who took nicotinamide daily developed fewer non-melanoma lesions
Source: HealthDay
Related MedlinePlus Pages: B Vitamins, Skin Cancer, Sun Exposure (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 21, 2015 Category: Consumer Health News Source Type: news
Concerns Over Sudden Increase in Radiation for Skin CancerConcerns Over Sudden Increase in Radiation for Skin Cancer
The use of first-line electronic brachytherapy for nonmelanoma skin cancer has risen 20-fold, raising concerns over inappropriate use. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 21, 2015 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Vitamin B3 derivative cuts risk of new skin cancers
(University of Sydney) A year of treatment with nicotinamide, a form of vitamin B3, significantly lowered the risk of common, non-melanoma skin cancer in high-risk patients, according to University of Sydney research published today in the New England Journal of Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 21, 2015 Category: Cancer & Oncology Source Type: news
Nonmelanoma skin cancer initially misdiagnosed in 36% of small cohort
In a small sample study, 10 (36%) of 28 children and young adults diagnosed with nonmelanoma skin cancer were given a misdiagnosis initially, suggesting that young patients with NMSC risk factors may require heightened monitoring from health care providers, according to a study published in Journal... (Source: Skin and Allergy News)
Source: Skin and Allergy News - October 20, 2015 Category: Dermatology Source Type: news
BRAF May Be a Good 'Target' in Nonmelanoma CancersBRAF May Be a Good 'Target' in Nonmelanoma Cancers
Early findings from a 'basket study' suggest that BRAF V600 may be a targetable oncogene in malignancies other than melanoma. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 19, 2015 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
